Back to home pageProfessional Education

The resident must meet the following requirements for employment at Beaumont Hospital as the PGY-2 Critical Care resident:

  • licensed pharmacist or eligible for licensure in the State of Michigan (including controlled substance license)
  • successful completion of a PGY-1 ASHP accredited residency

Longitudinal Requirements

  • complete all scheduled presentations, including pharmacy noon conference (3 total) and pharmacy grand rounds (1) 
  • complete MUE or Medication Safety Project and present findings at ASHP Midyear Clinical Meeting or another national conference at the discretion of the RPD
  • complete 2 of the following 3 projects: 
    • MUE (if not already completed)
    • Medication Safety Project (if not already completed)
    • complete the requirements for submission for publication of a review article, case report, drug information question or another project at the discretion of the residency program director and steering committee
    • complete the requirement for the Teaching Certificate Program at WSU if not already completed during PGY-1 Residency
  • update and maintain residency binder
  • maintain consistent documentation of interventions during both weekends and all rotations
  • meets weekend staffing requirements for the entire residency year (every third weekend)
  • support the precepting of Doctor of Pharmacy Students and PGY-1 Pharmacy Residents (if applicable)
  • present 2 CEs to Pharmacy Staff (residency project results and another of resident’s choosing)
  • present a total of 4 Journal Clubs to Pharmacy staff and 4 formal presentations to non-pharmacy personnel
  • active participation in the Critical Care Subcommittee of the P&T
  • achieve ACLS certification
  • complete research project



Copyright © Beaumont Health. All Rights Reserved.
Beaumont Health
2021
Beaumont Logo
logo
Beaumont Health is Michigan's largest health care system providing compassionate, extraordinary care to patient and families. Your partner in education and development.